![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/48 | |
A61K 31/496 | |||
A61K 31/495 | |||
A61K 31/4704 | |||
A61K 47/12 | |||
A61K 9/14 | |||
A61K 9/20 | |||
A61K 31/4965 | |||
A61K 9/28 |
(11) | Number of the document | 2800558 |
(13) | Kind of document | T |
(96) | European patent application number | 13733789.5 |
Date of filing the European patent application | 2013-01-04 | |
(97) | Date of publication of the European application | 2014-11-12 |
(45) | Date of publication and mention of the grant of the patent | 2018-04-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/KR2013/000057 |
Date | 2013-01-04 |
(87) | Number | WO 2013/103262 |
Date | 2013-07-11 |
(30) | Number | Date | Country code |
20120001954 | 2012-01-06 | KR |
(72) |
KWON, Taek Kwan, KR
KIM, Dong Ho, KR
KIM, Kyeong Soo, KR
KIM, Yong Il, KR
PARK, Jae Hyun, KR
WOO, Jong Soo, KR
|
(73) |
Hanmi Pharm. Co., Ltd.,
214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-958,
KR
|
(54) | STABLE PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND MONTELUKAST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
STABLE PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND MONTELUKAST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |